...
首页> 外文期刊>癌と化学療法 >Case report of two colorectal cancer patients with liver metastasis showing favorable response to fluorouracil and l-leucovorin therapy
【24h】

Case report of two colorectal cancer patients with liver metastasis showing favorable response to fluorouracil and l-leucovorin therapy

机译:肝转移患者对肝转移患者的案例报告显示对氟尿嘧啶和L-Leucovorin治疗的有利反应

获取原文
获取原文并翻译 | 示例

摘要

We treated 2 patients with colorectal cancer accompanied by liver metastasis who showed favorable response to combined treatment with fluorouracil and l-Leucovorin. Case 1 was a 40-year-old man with rectal carcinoma (moderately differentiated adenocarcinoma; se, n1, p1, H0, stage IV). He underwent low anterior resection of the rectum and postoperatively showed an increase peritoneal dissemination and liver metastasis. The patient was given 600 mg/m2 fluorouracil and 250 mg/m2 l-Leucovorin concomitantly for 7 courses. At course 3, the liver metastasis showed partial response and, during the 18 months after the 7th course, his peritoneal dissemination and other lesions were well controlled. As of 30 months post-treatment the patient was alive. Case 2 was a 60-year-old man with rectal carcinoma (well differentiated adenocarcinoma; ss, n1, p0, H1, stage IV). He underwent low anterior resection and postoperatively was given 3 courses of fluorouracil and l-Leucovorin. At course 2, he showed complete response, and, at present 8 months after the 2 courses, the patient continues to show complete response. Adverse drug reactions in both patients were controlled on an outpatient basis. While in the past liver metastasis has been treated by hepatic arterial infusion chemotherapy, a combination therapy with fluorouracil and l-Leucovorin can be used on an outpatient basis and results in a favorable response. This suggests that this combination therapy has clinical significance.
机译:我们治疗了2例结直肠癌患者,伴随着肝脏转移,他们表现出对氟尿嘧啶和L-Leucovorin合并治疗的有利反应。案例1是一名40岁的男性,直肠癌(适度分化的腺癌; SE,N1,P1,H0,第IV阶段)。他接受了直肠的低前进切除,并且术后表现出增加腹膜传播和肝转移。患者伴随着600mg / m2氟尿嘧啶和250mg / m 2 l-Leucovorin,恰好用于7个课程。在3,肝转移显示部分反应,并且在第7课程后18个月内,他的腹膜传播和其他病变良好控制。截至治疗后30个月,患者活着。案例2是一名60岁的人,直肠癌(分化良好的腺癌; SS,N1,P0,H1,第IV阶段)。他接受了低前进切除和术后3次氟尿嘧啶和L-Leucovorin。在第2阶段,他表现出完全的反应,并在2个课程后8个月,患者继续表现出完全反应。两种患者的不良药物反应在外部基础上控制。虽然在过去的肝脏转移中被肝动脉输液化疗治疗,但是用氟尿嘧啶和L-白叶素的联合治疗可以在门诊基础上使用,并导致有利的反应。这表明这种联合治疗具有临床意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号